Cargando…
The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the nor...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447498/ https://www.ncbi.nlm.nih.gov/pubmed/29396691 http://dx.doi.org/10.1007/s00125-017-4538-2 |
_version_ | 1783408504171659264 |
---|---|
author | Benitez-Aguirre, Paul Z. Wong, Tien Y. Craig, Maria E. Davis, Elizabeth A. Cotterill, Andrew Couper, Jennifer J. Cameron, Fergus J. Mahmud, Farid H. Jones, Tim W. Hodgson, Lauren A. B. Dalton, R. Neil Dunger, David B. Donaghue, Kim C. |
author_facet | Benitez-Aguirre, Paul Z. Wong, Tien Y. Craig, Maria E. Davis, Elizabeth A. Cotterill, Andrew Couper, Jennifer J. Cameron, Fergus J. Mahmud, Farid H. Jones, Tim W. Hodgson, Lauren A. B. Dalton, R. Neil Dunger, David B. Donaghue, Kim C. |
author_sort | Benitez-Aguirre, Paul Z. |
collection | PubMed |
description | AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in 963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A validated algorithm was used to categorise log(10) ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program, determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously and categorically (in quintiles: Q1–Q5) for associations with log(10) ACR and ACR risk groups. RESULTS: Greater log(10) ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vs Q1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR 2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of duration, blood pressure, BMI and blood glucose control. CONCLUSIONS/INTERPRETATION: Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore, RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before onset of clinical diabetes complications. |
format | Online Article Text |
id | pubmed-6447498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-64474982019-04-17 The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes Benitez-Aguirre, Paul Z. Wong, Tien Y. Craig, Maria E. Davis, Elizabeth A. Cotterill, Andrew Couper, Jennifer J. Cameron, Fergus J. Mahmud, Farid H. Jones, Tim W. Hodgson, Lauren A. B. Dalton, R. Neil Dunger, David B. Donaghue, Kim C. Diabetologia Article AIMS/HYPOTHESIS: We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes. METHODS: A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in 963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A validated algorithm was used to categorise log(10) ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program, determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously and categorically (in quintiles: Q1–Q5) for associations with log(10) ACR and ACR risk groups. RESULTS: Greater log(10) ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vs Q1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR 2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of duration, blood pressure, BMI and blood glucose control. CONCLUSIONS/INTERPRETATION: Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore, RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before onset of clinical diabetes complications. Springer Berlin Heidelberg 2018-02-02 2018 /pmc/articles/PMC6447498/ /pubmed/29396691 http://dx.doi.org/10.1007/s00125-017-4538-2 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Benitez-Aguirre, Paul Z. Wong, Tien Y. Craig, Maria E. Davis, Elizabeth A. Cotterill, Andrew Couper, Jennifer J. Cameron, Fergus J. Mahmud, Farid H. Jones, Tim W. Hodgson, Lauren A. B. Dalton, R. Neil Dunger, David B. Donaghue, Kim C. The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title | The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title_full | The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title_fullStr | The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title_full_unstemmed | The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title_short | The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
title_sort | adolescent cardio-renal intervention trial (addit): retinal vascular geometry and renal function in adolescents with type 1 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447498/ https://www.ncbi.nlm.nih.gov/pubmed/29396691 http://dx.doi.org/10.1007/s00125-017-4538-2 |
work_keys_str_mv | AT benitezaguirrepaulz theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT wongtieny theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT craigmariae theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT daviselizabetha theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT cotterillandrew theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT couperjenniferj theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT cameronfergusj theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT mahmudfaridh theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT jonestimw theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT hodgsonlaurenab theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT daltonrneil theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT dungerdavidb theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT donaghuekimc theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT theadolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT benitezaguirrepaulz adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT wongtieny adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT craigmariae adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT daviselizabetha adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT cotterillandrew adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT couperjenniferj adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT cameronfergusj adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT mahmudfaridh adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT jonestimw adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT hodgsonlaurenab adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT daltonrneil adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT dungerdavidb adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT donaghuekimc adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes AT adolescentcardiorenalinterventiontrialadditretinalvasculargeometryandrenalfunctioninadolescentswithtype1diabetes |